Making the Case for UK Medicines Manufacturing

Dear colleague

The ABPI and MHRA are delighted to invite you to register for “Making the case for UK medicines manufacturing” – a must-attend event for senior leaders and decision makers with strategic responsibility for securing, developing and future-proofing manufacturing networks in the pharmaceutical industry.

The event will ask tough questions of leading speakers from government, industry and MHRA:

• what are the unique selling points of the UK in relation to manufacturing?

• how can the collective nature of the landscape facilitate and de-risk the decision to manufacture medicines in the UK?

Learn about the UK’s pragmatic and supportive regulatory environment. Understand how to utilise a skilled UK workforce and discover more about the fiscal flexibilities that help make the UK a competitive proposition for manufacturing in the pharmaceutical and service industry.

With keynote speakers from across Government, Industry and the MHRA this is your opportunity to discuss, network and participate in shaping the priorities of the sector and its challenges. This event is a must for those involved in the manufacturing of medicines from both within the pharmaceutical industry and across the service industry

Confirmed speakers

Gerald Heddell | Director of Inspection, Enforcement and Standards, Medicines & Healthcare products Regulatory Agency

Ian McCubbin | Senior Vice President, North America, Japan & Global Pharma Supply – GMS, GlaxoSmithKline

Johnathon Marshall | Partner, PWC

Jon Mowles | Sector Specialist, Life Sciences Organisation, UK Trade & Investment

James Christie | Project Director, Medicines Manufacturing Industry Partnership (MMIP)

Date

Wednesday 2 March, 2016, 9:00 AM - 4:30 PM

Venue

The Royal Society of Medicine,1 Wimpole Street, London, W1G 0AE

For more information and to register please visit the Event Website. Please do pass this invitation onto interested colleagues within your organisation.